Cargando…

Clinical Management of Locally Advanced Basal-Cell Carcinomas and Future Therapeutic Directions

Treatment of choice for nodular basal-cell carcinomas (BCCs) is complete excision, implying that small lesions are of minor concern. Metastasis is very rare (< 1%). However, locally advanced basal-cell carcinomas (laBCCs), which are ineligible for surgery or radiation, are a therapeutic challenge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niebel, Dennis, Sirokay, Judith, Hoffmann, Friederike, Fröhlich, Anne, Bieber, Thomas, Landsberg, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367955/ https://www.ncbi.nlm.nih.gov/pubmed/32383019 http://dx.doi.org/10.1007/s13555-020-00382-y

Ejemplares similares

Talimogene Laherparepvec in Advanced Mucosal Melanoma of the Urethra Upon Primary Resistance on Immune Checkpoint Inhibition: A Case Report
por: Fröhlich, Anne, et al.
Publicado: (2020)

Grzybowski’s Generalized Eruptive Keratoacanthomas in a Patient with Terminal Kidney Disease—An Unmet Medical Need Equally Ameliorated by Topical Imiquimod Cream and Lapacho Tea Wraps: A Case Report
por: Havenith, Regina, et al.
Publicado: (2021)

Talimogene laherparepvec treatment to overcome loco-regional acquired resistance to immune checkpoint blockade in tumor stage IIIB–IV M1c melanoma patients
por: Fröhlich, Anne, et al.
Publicado: (2020)

DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy
por: Niebel, Dennis, et al.
Publicado: (2022)

Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma
por: Hoffmann, Friederike, et al.
Publicado: (2020)

Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma
por: Fröhlich, Anne, et al.
Publicado: (2020)

Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions
por: Niebel, Dennis, et al.
Publicado: (2023)

H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade
por: Hoffmann, Friederike, et al.
Publicado: (2020)

Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations
por: Mohan, Shalini V., et al.
Publicado: (2014)

Locally Advanced Basal Cell Carcinoma with Intraocular Invasion
por: Tchernev, Georgi, et al.
Publicado: (2018)

Treatment of Locally Advanced Basal Cell Carcinomas with Vismodegib
por: Mastronardi, Luis, et al.
Publicado: (2021)

Vismodegib in Locally Advanced Basal Cell Carcinoma in Slovenia
por: Mesti, Tanja, et al.
Publicado: (2022)

Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma
por: Chen, Olivia M., et al.
Publicado: (2022)

Current Perspectives in the Treatment of Locally Advanced Basal Cell Carcinoma
por: Gupta, Neha, et al.
Publicado: (2022)

Sonidegib treatment in patients with locally advanced basal cell carcinoma
por: Villani, Alessia, et al.
Publicado: (2022)

Signaling Pathways and Therapeutic Strategies in Advanced Basal Cell Carcinoma
por: Vallini, Giulia, et al.
Publicado: (2023)

Vismodegib and orbital excision for treating locally advanced basal cell carcinoma
por: Hogarty, Daniel T, et al.
Publicado: (2018)

Sonidegib with and Without Adjunctive Treatment for Locally Advanced Basal Cell Carcinomas
por: Villani, Alessia, et al.
Publicado: (2022)

Degree of Actinic Elastosis Is a Surrogate of Exposure to Chronic Ultraviolet Radiation and Correlates More Strongly with Cutaneous Squamous Cell Carcinoma than Basal Cell Carcinoma
por: Drexler, Konstantin, et al.
Publicado: (2023)

Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
por: FETTER, Tanja, et al.
Publicado: (2020)

Role of topical tranexamic acid in hemostasis of locally advanced basal cell carcinoma
por: Wong, Yisheng, et al.
Publicado: (2016)

Electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinomas
por: Kis, Erika Gabriella, et al.
Publicado: (2019)

Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma: A Retrospective Study
por: HERMS, Florian, et al.
Publicado: (2022)

Long-Term Management of Advanced Basal Cell Carcinoma: Current Challenges and Future Perspectives
por: Heppt, Markus V., et al.
Publicado: (2022)

Immunostimulatory Endogenous Nucleic Acids Perpetuate Interface Dermatitis—Translation of Pathogenic Fundamentals Into an In Vitro Model
por: Braegelmann, Christine, et al.
Publicado: (2021)

Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma
por: Fröhlich, Anne, et al.
Publicado: (2020)

Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma
por: Yurchenko, Andrey A., et al.
Publicado: (2022)

Non-surgical Management of Locally Advanced Basal Cell Carcinoma of the Upper Extremity With Vismodegib
por: Swisher, Austin R, et al.
Publicado: (2022)

Benefit–risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma
por: García Ruiz, Antonio J, et al.
Publicado: (2022)

The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area
por: Villani, Alessia, et al.
Publicado: (2023)

Recent Advances and Future Directions in Downstream Processing of Therapeutic Antibodies
por: Matte, Allan
Publicado: (2022)

Intracellular delivery of therapeutic proteins. New advancements and future directions
por: Porello, Ilaria, et al.
Publicado: (2023)

Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions
por: Abdeldaim, Dalia T., et al.
Publicado: (2023)

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions
por: Haddad, R I, et al.
Publicado: (2018)

Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): Neoadjuvant Vismodegib in Locally Advanced Basal Cell Carcinoma
por: Bertrand, Nicolas, et al.
Publicado: (2021)

Advances in the management of basal cell carcinoma
por: Lewin, Jesse M., et al.
Publicado: (2015)

Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
por: Niebel, Dennis, et al.
Publicado: (2021)

Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients—Focus on Clinical and Histopathological Variation
por: Niebel, Dennis, et al.
Publicado: (2022)

Locally Advanced Cancer of the Esophagus, Current Treatment Strategies, and Future Directions
por: Rahma, Osama E., et al.
Publicado: (2012)

Vismodegib: First-in-Class Hedgehog Pathway Inhibitor for Metastatic or Locally Advanced Basal Cell Carcinoma
por: Nix, Nancy M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tpo22u98vtd88f6911pei4t4ja